Crippa F - Search Results

1

The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan.

Seregni E, Bombardieri E, Bogni A, Crippa F, De Jager E, Buraggi GL. Seregni E, et al. Among authors: crippa f. Int J Biol Markers. 1992 Jul-Sep;7(3):167-70. doi: 10.1177/172460089200700308. Int J Biol Markers. 1992. PMID: 1431340

2

Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.

Boccardo F, Bombardieri E, Zanardi S, Valenti G, Zanaboni F, Valtolina M, Seregni E, Crippa F. Boccardo F, et al. Among authors: crippa f. Int J Biol Markers. 1991 Jan-Mar;6(1):12-20. doi: 10.1177/172460089100600103. Int J Biol Markers. 1991. PMID: 1856512

3

Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study.

Crippa F, Presti M, Marini A, D'Onofrio B, Bolis G, Buraggi GL. Crippa F, et al. Int J Biol Markers. 1990 Jul-Sep;5(3):103-8. Int J Biol Markers. 1990. PMID: 2286774

4

Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.

Seregni E, Crippa F, Botti C, Bellotti MG, Bogni A, Pizzichetta M, Bombardieri E. Seregni E, et al. Among authors: crippa f. Int J Biol Markers. 1993 Apr-Jun;8(2):124-9. doi: 10.1177/172460089300800209. Int J Biol Markers. 1993. PMID: 8366295

5

Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.

Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL. Crippa F, et al. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):52-5. J Nucl Biol Med (1991). 1992. PMID: 1450226

6

EIA/IRMA test for cytokeratin 19 determination.

Bogni A, Seregni E, Botti C, Foa P, Cataldo I, Crippa F, Bombardieri E. Bogni A, et al. Among authors: crippa f. Int J Biol Markers. 1993 Jul-Sep;8(3):200-1. doi: 10.1177/172460089300800312. Int J Biol Markers. 1993. PMID: 7506285 No abstract available.

7

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer.

Crippa F, Bolis G, Seregni E, Gavoni N, Scarfone G, Ferraris C, Buraggi GL, Bombardieri E. Crippa F, et al. Eur J Cancer. 1995;31A(5):686-90. doi: 10.1016/0959-8049(94)00454-d. Eur J Cancer. 1995. PMID: 7640039

8

Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients.

Bogni A, Cortinois A, Grasselli G, Seregni E, Crippa F, Castellani MR, Bombardieri E. Bogni A, et al. Among authors: crippa f. J Biol Regul Homeost Agents. 1994 Oct-Dec;8(4):121-5. J Biol Regul Homeost Agents. 1994. PMID: 7660854

9

Evaluation of serum osteocalcin and myosin in pediatric patients affected by osteosarcoma and rhabdomyosarcoma.

Seregni E, Luksch R, Crippa F, Bruni GF, Bombardieri E. Seregni E, et al. Among authors: crippa f. Int J Biol Markers. 1994 Oct-Dec;9(4):260-1. doi: 10.1177/172460089400900413. Int J Biol Markers. 1994. PMID: 7836807 No abstract available.

10

Bone scintigraphy in breast cancer: a ten-year follow-up study.

Crippa F, Seregni E, Agresti R, Bombardieri E, Buraggi GL. Crippa F, et al. J Nucl Biol Med (1991). 1993 Jun;37(2):57-61. J Nucl Biol Med (1991). 1993. PMID: 8373834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters